期刊文献+

Aβ1-40脑内注射对大鼠海马AchE和NOS1表达的影响及加减地黄饮子的干预作用 被引量:12

Interference effects of Extracts from Modified Decoction of Rehmanniae(加减地黄饮子) on the expressing of AchE and NOS1 in hippocampus of AD rats
下载PDF
导出
摘要 目的:观察加减地黄饮子对β-淀粉样蛋白1-40(Aβ1-40)诱导的AD模型大鼠大脑海马组织AchE和NOS1表达的影响。方法:采用大鼠海马立体定向注射凝聚态Aβ1-40诱导老年性痴呆(Alzheimer's disease,AD)动物模型。采用免疫组织化学染色法和计算机图像分析技术测定海马区AchE和NOS1表达。结果:模型组(6.42±0.38)AchE表达与假手术组(6.74±0.47)比较无显著性差异。与模型组比较,加减地黄饮子组(3.77±0.29)AchE表达明显减少,作用效应较盐酸多奈哌齐(2.25±0.20)弱。与假手术组(5.74±0.39)相比,模型组大鼠海马区NOS1表达下降(2.38±030),与模型组比较,地黄饮子组NOS1的表达增加(4.43±0.40),作用优于盐酸多奈哌齐(3.56±0.27)。结论:加减地黄饮子可通过抑制AD模型大鼠海马组织AchE和上调AD模型大鼠海马组织NOS1表达而发挥抗AD的作用。 Objective: To observe the effects of Modified Decoction of Rehmanniae on expression of Ache 和 NOS1 protein in hippocampal in Alzheimer's disease rats induced by amyloid - β1 - 40 injection into brain. Methods: AD model in rats was induced by amyloid - β1 - 40 sterotaxis injection the bilateral hippocampus. Modified Decoction of Rehmanniae was geven by oral administration for 28 days. the expression levels of AchE 和 NOS1 protein in the hippocampus were measured by immunohistochemical SABC techniques. Results: the levels of AchE expression from t the Modified Decoction of Rehmanniae group ( 3.77 ± 0.29) was significantly lower than that in the model group (6.42 ± 0.38, p 〈 0.05 ) , and the levels of NOS1 expression from the model group (2.38 ± 030) was significantly Lower than that in the sham group ( 5.74 ± 0.39 ) , and that from the Modified Decoction of Rehmanniae group (4.43 ± 0.40 ) was significantly highter than in the model group ( p 〈 0.05 ). Conclusions: Modified Decoction of Rehmanniae has sighificant inhibitory effects on expression of AchE and Up - regulateing NOS1 in hippocampus of AD rats, and could be used as an effective drug for AD
出处 《中药药理与临床》 CAS CSCD 北大核心 2007年第5期149-151,共3页 Pharmacology and Clinics of Chinese Materia Medica
关键词 加减地黄饮子 乙酰胆碱酯酶 神经元型一氧化氮合酶 Alzheimer's disease Modified Decoction of Rehmanniae(加减地黄饮子) AchE NOS1
  • 相关文献

参考文献7

  • 1Geerts H, Grossberg GT. Pharmacology of acetylcholinesterase inhibitors and N - methyl - D - aspartate receptors for combination therapy in the treatment of Alzheimer's disease. J Clin Pharmacol,2006; 46(7): 8 -16
  • 2谢宁,牛英才,宋琳,邹纯朴.加减地黄饮子对Aβ-40所致痴呆大鼠学习记忆、脑酶活性的影响[J].中医药信息,2004,21(2):57-58. 被引量:30
  • 3谢宁,牛英才,刘殊,关慧波,宋琳.加减地黄饮子提取工艺的研究[J].中医药学报,2004,32(4):26-29. 被引量:10
  • 4Vignini A, Nanetti L, Moroni C, et al. Modifications of platelet from Alzheimer disease patients: a possible relation between membrane properties and NO metabolites. Neurobiol Aging, 2007; 28(7): 987 -994
  • 5Torre JC, Aliev G. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes. J Cereb Blood Flow Metab ,2005 ; 25 (6) : 663 - 672
  • 6Bartolucci C, Siotto M, Ghidini E, et al. Structural determinants of Torpedo califomica acetylcholinesterase inhibition by the novel and orally active carbamate based anti - alzheimer drug ganstigmine ( CHF - 2819). J Med Chem, 2006; 49( 17): 5051 -5058
  • 7Monte - Millan M, Garcia - Palomero E, Valenzuela R, et al. Dual binding site acetylcholinesterase inhibitors : potential new disease - modifying agents for AD. J Mol Neurosci, 2006 ;30 ( 1 -2) : 85 - 88

二级参考文献3

共引文献32

同被引文献182

引证文献12

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部